Research & development > Clinical diagnostics

Positive phase 1 results for Admedus herpes trial

03 February, 2014

Healthcare company Admedus today announced interim study results on its phase 1 trial of a therapeutic vaccine for herpes simplex virus (HSV-2). The vaccine was found to be safe in the study subjects and was able to generate a T-cell response.


Modelling ovarian cancer

29 January, 2014

Scientists at Queensland University of Technology (QUT), funded by Cancer Council Queensland, are conducting research into the deadliest form of ovarian cancer.


Non-invasive, risk-free screen for Down syndrome

13 January, 2014

Researchers at Curtin University have assessed the use of a new non-invasive prenatal testing (NIPT) technique to identify Down syndrome in foetuses.


HPV testing at home

09 January, 2014

A Lund University study has found that HPV self-testing is as effective as tests done by doctors and, more importantly, more comfortable for women who find regular smear tests unpleasant.


Immunisation checks: there's an app for that

12 December, 2013

Cambridge Consultants and Diagnostics For All are working together to demonstrate a mobile phone application that can read a simple test for whether a child has been immunised.


South Australia's first autoimmune blood bank

07 November, 2013

Scientists from Flinders University and SA Pathology are setting up South Australia's first autoimmune blood bank, providing a central depository for research into different autoimmune diseases.


New nanoparticle delivers and monitors cancer drugs

01 November, 2013

Chemical engineers at the University of New South Wales (UNSW) have synthesised an iron oxide nanoparticle (IONP) that delivers cancer drugs to cells while simultaneously monitoring the drug release in real time.


University of Melbourne enters Parkinson's treatment deal

11 October, 2013

The University of Melbourne has entered into a drug development deal with Procypra Therapeutics, a US start-up company established by Collaborative Medicinal Development under the umbrella of venture capital firm Cthulhu Ventures.


Peanut butter can diagnose Alzheimer's disease

11 October, 2013

Health researchers at the University of Florida have found a quick and cheap way to test for early-stage Alzheimer's disease. The only equipment necessary is a container of peanut butter and a ruler.


Clinical Genomics acquisition brings bowel cancer blood test to the fore

09 October, 2013

Clinical Genomics - the developer of a blood-based biomarker test in collaboration with CSIRO Preventative Health Flagship and the Flinders Centre for Innovation in Cancer - has acquired US-based screening company Enterix from Quest Diagnostics, as well as its Sydney-based subsidiary.


Why some people don't get as sick and a universal flu vaccine

23 September, 2013

Investigating why some people seem to resist severe illness has led scientists closer to developing a universal flu vaccine.


Rapid diagnostic test for deadly tropical disease

20 September, 2013

Researchers from James Cook University (JCU) and The Townsville Hospital have developed a highly sensitive and rapid multiplex diagnostic test for melioidosis. Their findings have been published in the journal Diagnostic Microbiology and Infectious Diseases.


Hypertension drugs increase the effect of chemo in childhood cancer

23 August, 2013 by Lauren Davis

Beta-blockers are traditionally used in the treatment of high blood pressure, but researchers at the Children’s Cancer Institute Australia (CCIA) have found that they can also increase the effectiveness of chemotherapy in treating aggressive childhood cancers such as neuroblastoma.


Partnership to prepare for the next pandemic

25 July, 2013

A $20 million research partnership between Australia, Singapore and the US aims to prepare the world for its next pandemic.


Both brains and genes linked to Alzheimer’s disease

15 July, 2013 by Lauren Davis

Australian research, presented at the Alzheimer’s Association International Conference this week, has highlighted the links between a person’s brain chemistry, genes and their risk of developing Alzheimer’s disease (AD).


  • All content Copyright © 2025 Westwick-Farrow Pty Ltd